Prio Wealth Limited Partnership’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$44.5K Hold
941
﹤0.01% 264
2024
Q2
$47.3K Hold
941
﹤0.01% 257
2024
Q1
$105K Hold
941
﹤0.01% 266
2023
Q4
$54.6K Hold
941
﹤0.01% 255
2023
Q3
$29.9K Hold
941
﹤0.01% 247
2023
Q2
$77.4K Hold
941
﹤0.01% 251
2023
Q1
$96.7K Hold
941
﹤0.01% 245
2022
Q4
$138K Hold
941
0.01% 246
2022
Q3
$159K Hold
941
0.01% 243
2022
Q2
$109K Hold
941
﹤0.01% 250
2022
Q1
$94K Hold
941
﹤0.01% 262
2021
Q4
$146K Hold
941
﹤0.01% 270
2021
Q3
$222K Hold
941
0.01% 260
2021
Q2
$320K Hold
941
0.01% 231
2021
Q1
$381K Hold
941
0.01% 216
2020
Q4
$626K Hold
941
0.02% 165
2020
Q3
$438K Hold
941
0.02% 177
2020
Q2
$551K Hold
941
0.03% 164
2020
Q1
$137K Hold
941
0.01% 229
2019
Q4
$135K Hold
941
0.01% 256
2019
Q3
$37K Hold
941
﹤0.01% 256
2019
Q2
$95K Hold
941
﹤0.01% 242
2019
Q1
$123K Hold
941
0.01% 237
2018
Q4
$95K Hold
941
0.01% 219
2018
Q3
$235K Hold
941
0.01% 223
2018
Q2
$420K Hold
941
0.02% 178
2018
Q1
$371K Buy
+941
New +$371K 0.02% 183